Novellia Snags $18M for Its Real-World Data Platform 

Novellia raised $18 million in Series A funding to scale its platform, which helps patients consolidate medical records and share anonymized data with pharma companies. CEO Shashi Shankar argued that sourcing data directly from patients can create more complete healthcare datasets and improve drug research. The post Novellia Snags $18M for Its Real-World Data Platform …

Read More

AI for MSK Will Bend the Healthcare Cost Curve

Access to AI-powered digital MSK care options reduces wait times and allows patients to move directly into the right care instead of stair-stepping from hospital inpatient to primary care physicians to physical therapy. The post AI for MSK Will Bend the Healthcare Cost Curve appeared first on MedCity News.

Read More

Servier Moves Into Muscular Dystrophy, Paying $1.5B for Assets From Edgewise Therapeutics

France-based pharma company Servier is acquiring the muscular dystrophy business of Edgewise Therapeutics as part of a revenue growth strategy in oncology and neurology. The deal brings an Edgewise drug in clinical development for two rare neuromuscular disorders with limited treatment options. The post Servier Moves Into Muscular Dystrophy, Paying $1.5B for Assets From Edgewise…

Read More